Niki Katsara Antonakea

Niki Katsara is an MD candidate at Charité Medical University in Berlin, Germany. She was born and raised in Athens, Greece, where she graduated from the German School of Athens (DSA). Currently, she serves as a Postgraduate Research Fellow at the esteemed Yale Interventional Oncology Lab, where she aims to improve the detection, characterization, and treatment of neoplastic disease in the liver using machine learning to combine imaging and clinical parameters to create powerful predictive algorithms and upgrade the imaging quality during minimal-invasive treatments. Her main medical interests include Gynaecology/Oncology and Interventional Radiology/Oncology. Driven by a profound fascination for cancers and women's health, she actively seeks opportunities for collaboration, research engagement, and clinical electives.

Beyond her academic pursuits, Niki Katsara is deeply committed to combining her future clinical work with global health and advocacy for patients' needs. With experiences spanning medical programs in Tanzania (ROAD2IR) and Japan, coupled with her European background and active involvement in pan-Arabian initiatives (PARSGO) and Canadian-based organizations (HPV Global Action), she seeks a deeper understanding of diverse healthcare systems. She upholds the ethos of inclusive healthcare delivery, firmly believing in the provision of medicine without barriers, irrespective of socio-economic, cultural, or geographical backgrounds. She is deeply committed to ensuring equitable access to medical care for all individuals in the future, embodying a steadfast dedication to addressing healthcare disparities and fostering a healthcare landscape that is universally accessible and compassionate.

Joining the Yale School of Medicine community represents the realization of a long-standing dream. Her ultimate goal is to harness the extensive resources offered by the Yale School of Medicine to further her journey as an excellent physician-scientist. Together, she envisions a collaborative effort to combat cancers and enhance the quality of life for patients worldwide.